Fullerton Health Pte. Ltd. ("Fullerton Health" or the "Company"), a leading healthcare solutions provider operating in nine markets across Asia-Pacific,  announced that Mitsubishi Corporation has acquired a strategic minority stake in the Company. This partnership marks a significant milestone in Fullerton Health's growth journey, enabling greater shareholder alignment as the Company sharpens its focus on regional growth and accelerates its vision for integrated, digitally enabled care and service.

This investment, which concludes a series of minority investments including that of Far East Drug's, will propel Fullerton Health's continued expansion in existing markets – particularly in Singapore, Indonesia and the Philippines where its presence is strongest – while actively pursuing strategic entry into new ones across the region. The Company will leverage its robust footprint as well as digital and AI capabilities to roll out regional and local solutions on a fully integrated platform.

"This partnership reflects strong alignment between Mitsubishi Corporation and our existing shareholders on the long-term value and industry leadership potential of Fullerton Health. With a shared commitment to impact and innovation, we are well positioned to achieve our aim to positively impact 10 million lives in coming years. We will do this by scaling sustainably, strengthening our market leadership, and delivering greater value to all our stakeholders," said Ho Kuen Loon, Group Chief Executive Officer and Non-executive Director, Fullerton Health.

BofA Securities acted as the sole financial advisor to Fullerton Health.